SLC7A5 and hepatocellular carcinoma: It has been shown that YAP1 and TAZ bind directly to the SLC7A5 promoter to upregulate its transcription and inhibition of SLC7A5 blocks YAP1/TAZ-mediated tumorigenesis of hepatocellular carcinoma.